The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Implantable Drug Delivery Systems-Global Market Insights and Sales Trends 2025
Synopsis
Drug delivery system introduces therapeutic substance in the body as formulation or device to improve its efficiency and safety. There was requirement drug delivery system that could maintain the steady release of therapeutic drugs within the specific site. Implantable drug delivery system becomes new kind of drug delivery system which can directly implant in the human body to optimize therapeutic properties. This system is more steady, effective, safe and reliable than other drug delivery system. For intravenous drug delivery system, drugs actions were short, and frequent injections were required. For topical drug delivery system, absorption drug may be limited due physiochemical characteristic of drugs. Implantable drug delivery system does not have limitation associated with intravenous and topical drug delivery system beside it is controlled drug delivery system.
The global Implantable Drug Delivery Systems market size is expected to reach US$ 666.9 million by 2029, growing at a CAGR of 5.1% from 2023 to 2029. The market is mainly driven by the significant applications of Implantable Drug Delivery Systems in various end use industries. The expanding demands from the Diabetic Retinopathy, Cardiovascular Diseases, Colorectal Cancer and Osteoporosis, are propelling Implantable Drug Delivery Systems market. Biodegradable, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-Biodegradable segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Implantable Drug Delivery Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Implantable Drug Delivery Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Implantable Drug Delivery Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Implantable Drug Delivery Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Implantable Drug Delivery Systems covered in this report include Boston Scientific Corporation, Bayer Healthcare, Medtronic Inc., Allergan Inc., Abbott laboratories, Bausch and Lomb Inc., Genetech Inc., PSivda Corporation and Medtronic, etc.
The global Implantable Drug Delivery Systems market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boston Scientific Corporation
Bayer Healthcare
Medtronic Inc.
Allergan Inc.
Abbott laboratories
Bausch and Lomb Inc.
Genetech Inc.
PSivda Corporation
Medtronic
Varian Medical System
Arrow International
Neurotech Pharmaceuticals
Replenish Inc.
Global Implantable Drug Delivery Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Implantable Drug Delivery Systems market, Segment by Type:
Biodegradable
Non-Biodegradable
Global Implantable Drug Delivery Systems market, by Application
Diabetic Retinopathy
Cardiovascular Diseases
Colorectal Cancer
Osteoporosis
Ocular Diseases
Brain Tumors
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Implantable Drug Delivery Systems companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Drug delivery system introduces therapeutic substance in the body as formulation or device to improve its efficiency and safety. There was requirement drug delivery system that could maintain the steady release of therapeutic drugs within the specific site. Implantable drug delivery system becomes new kind of drug delivery system which can directly implant in the human body to optimize therapeutic properties. This system is more steady, effective, safe and reliable than other drug delivery system. For intravenous drug delivery system, drugs actions were short, and frequent injections were required. For topical drug delivery system, absorption drug may be limited due physiochemical characteristic of drugs. Implantable drug delivery system does not have limitation associated with intravenous and topical drug delivery system beside it is controlled drug delivery system.
The global Implantable Drug Delivery Systems market size is expected to reach US$ 666.9 million by 2029, growing at a CAGR of 5.1% from 2023 to 2029. The market is mainly driven by the significant applications of Implantable Drug Delivery Systems in various end use industries. The expanding demands from the Diabetic Retinopathy, Cardiovascular Diseases, Colorectal Cancer and Osteoporosis, are propelling Implantable Drug Delivery Systems market. Biodegradable, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-Biodegradable segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Implantable Drug Delivery Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Implantable Drug Delivery Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Implantable Drug Delivery Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Implantable Drug Delivery Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Implantable Drug Delivery Systems covered in this report include Boston Scientific Corporation, Bayer Healthcare, Medtronic Inc., Allergan Inc., Abbott laboratories, Bausch and Lomb Inc., Genetech Inc., PSivda Corporation and Medtronic, etc.
The global Implantable Drug Delivery Systems market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boston Scientific Corporation
Bayer Healthcare
Medtronic Inc.
Allergan Inc.
Abbott laboratories
Bausch and Lomb Inc.
Genetech Inc.
PSivda Corporation
Medtronic
Varian Medical System
Arrow International
Neurotech Pharmaceuticals
Replenish Inc.
Global Implantable Drug Delivery Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Implantable Drug Delivery Systems market, Segment by Type:
Biodegradable
Non-Biodegradable
Global Implantable Drug Delivery Systems market, by Application
Diabetic Retinopathy
Cardiovascular Diseases
Colorectal Cancer
Osteoporosis
Ocular Diseases
Brain Tumors
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Implantable Drug Delivery Systems companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Implantable Drug Delivery Systems
1.1 Implantable Drug Delivery Systems Market Overview
1.1.1 Implantable Drug Delivery Systems Product Scope
1.1.2 Implantable Drug Delivery Systems Market Status and Outlook
1.2 Global Implantable Drug Delivery Systems Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Implantable Drug Delivery Systems Market Size by Region (2018-2029)
1.4 Global Implantable Drug Delivery Systems Historic Market Size by Region (2018-2023)
1.5 Global Implantable Drug Delivery Systems Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Implantable Drug Delivery Systems Market Size (2018-2029)
1.6.1 North America Implantable Drug Delivery Systems Market Size (2018-2029)
1.6.2 Europe Implantable Drug Delivery Systems Market Size (2018-2029)
1.6.3 Asia-Pacific Implantable Drug Delivery Systems Market Size (2018-2029)
1.6.4 Latin America Implantable Drug Delivery Systems Market Size (2018-2029)
1.6.5 Middle East & Africa Implantable Drug Delivery Systems Market Size (2018-2029)
2 Implantable Drug Delivery Systems Market by Type
2.1 Introduction
2.1.1 Biodegradable
2.1.2 Non-Biodegradable
2.2 Global Implantable Drug Delivery Systems Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Implantable Drug Delivery Systems Historic Market Size by Type (2018-2023)
2.2.2 Global Implantable Drug Delivery Systems Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Implantable Drug Delivery Systems Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Implantable Drug Delivery Systems Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Implantable Drug Delivery Systems Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Implantable Drug Delivery Systems Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Implantable Drug Delivery Systems Revenue Breakdown by Type (2018-2029)
3 Implantable Drug Delivery Systems Market Overview by Application
3.1 Introduction
3.1.1 Diabetic Retinopathy
3.1.2 Cardiovascular Diseases
3.1.3 Colorectal Cancer
3.1.4 Osteoporosis
3.1.5 Ocular Diseases
3.1.6 Brain Tumors
3.1.7 Other
3.2 Global Implantable Drug Delivery Systems Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Implantable Drug Delivery Systems Historic Market Size by Application (2018-2023)
3.2.2 Global Implantable Drug Delivery Systems Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Implantable Drug Delivery Systems Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Implantable Drug Delivery Systems Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Implantable Drug Delivery Systems Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Implantable Drug Delivery Systems Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Implantable Drug Delivery Systems Revenue Breakdown by Application (2018-2029)
4 Implantable Drug Delivery Systems Competition Analysis by Players
4.1 Global Implantable Drug Delivery Systems Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Implantable Drug Delivery Systems as of 2022)
4.3 Date of Key Players Enter into Implantable Drug Delivery Systems Market
4.4 Global Top Players Implantable Drug Delivery Systems Headquarters and Area Served
4.5 Key Players Implantable Drug Delivery Systems Product Solution and Service
4.6 Competitive Status
4.6.1 Implantable Drug Delivery Systems Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Boston Scientific Corporation
5.1.1 Boston Scientific Corporation Profile
5.1.2 Boston Scientific Corporation Main Business
5.1.3 Boston Scientific Corporation Implantable Drug Delivery Systems Products, Services and Solutions
5.1.4 Boston Scientific Corporation Implantable Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.1.5 Boston Scientific Corporation Recent Developments
5.2 Bayer Healthcare
5.2.1 Bayer Healthcare Profile
5.2.2 Bayer Healthcare Main Business
5.2.3 Bayer Healthcare Implantable Drug Delivery Systems Products, Services and Solutions
5.2.4 Bayer Healthcare Implantable Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.2.5 Bayer Healthcare Recent Developments
5.3 Medtronic Inc.
5.3.1 Medtronic Inc. Profile
5.3.2 Medtronic Inc. Main Business
5.3.3 Medtronic Inc. Implantable Drug Delivery Systems Products, Services and Solutions
5.3.4 Medtronic Inc. Implantable Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.3.5 Allergan Inc. Recent Developments
5.4 Allergan Inc.
5.4.1 Allergan Inc. Profile
5.4.2 Allergan Inc. Main Business
5.4.3 Allergan Inc. Implantable Drug Delivery Systems Products, Services and Solutions
5.4.4 Allergan Inc. Implantable Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.4.5 Allergan Inc. Recent Developments
5.5 Abbott laboratories
5.5.1 Abbott laboratories Profile
5.5.2 Abbott laboratories Main Business
5.5.3 Abbott laboratories Implantable Drug Delivery Systems Products, Services and Solutions
5.5.4 Abbott laboratories Implantable Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.5.5 Abbott laboratories Recent Developments
5.6 Bausch and Lomb Inc.
5.6.1 Bausch and Lomb Inc. Profile
5.6.2 Bausch and Lomb Inc. Main Business
5.6.3 Bausch and Lomb Inc. Implantable Drug Delivery Systems Products, Services and Solutions
5.6.4 Bausch and Lomb Inc. Implantable Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.6.5 Bausch and Lomb Inc. Recent Developments
5.7 Genetech Inc.
5.7.1 Genetech Inc. Profile
5.7.2 Genetech Inc. Main Business
5.7.3 Genetech Inc. Implantable Drug Delivery Systems Products, Services and Solutions
5.7.4 Genetech Inc. Implantable Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.7.5 Genetech Inc. Recent Developments
5.8 PSivda Corporation
5.8.1 PSivda Corporation Profile
5.8.2 PSivda Corporation Main Business
5.8.3 PSivda Corporation Implantable Drug Delivery Systems Products, Services and Solutions
5.8.4 PSivda Corporation Implantable Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.8.5 PSivda Corporation Recent Developments
5.9 Medtronic
5.9.1 Medtronic Profile
5.9.2 Medtronic Main Business
5.9.3 Medtronic Implantable Drug Delivery Systems Products, Services and Solutions
5.9.4 Medtronic Implantable Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.9.5 Medtronic Recent Developments
5.10 Varian Medical System
5.10.1 Varian Medical System Profile
5.10.2 Varian Medical System Main Business
5.10.3 Varian Medical System Implantable Drug Delivery Systems Products, Services and Solutions
5.10.4 Varian Medical System Implantable Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.10.5 Varian Medical System Recent Developments
5.11 Arrow International
5.11.1 Arrow International Profile
5.11.2 Arrow International Main Business
5.11.3 Arrow International Implantable Drug Delivery Systems Products, Services and Solutions
5.11.4 Arrow International Implantable Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.11.5 Arrow International Recent Developments
5.12 Neurotech Pharmaceuticals
5.12.1 Neurotech Pharmaceuticals Profile
5.12.2 Neurotech Pharmaceuticals Main Business
5.12.3 Neurotech Pharmaceuticals Implantable Drug Delivery Systems Products, Services and Solutions
5.12.4 Neurotech Pharmaceuticals Implantable Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.12.5 Neurotech Pharmaceuticals Recent Developments
5.13 Replenish Inc.
5.13.1 Replenish Inc. Profile
5.13.2 Replenish Inc. Main Business
5.13.3 Replenish Inc. Implantable Drug Delivery Systems Products, Services and Solutions
5.13.4 Replenish Inc. Implantable Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.13.5 Replenish Inc. Recent Developments
6 North America
6.1 North America Implantable Drug Delivery Systems Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Implantable Drug Delivery Systems Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Implantable Drug Delivery Systems Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Implantable Drug Delivery Systems Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Implantable Drug Delivery Systems Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Implantable Drug Delivery Systems Market Dynamics
11.1 Implantable Drug Delivery Systems Industry Trends
11.2 Implantable Drug Delivery Systems Market Drivers
11.3 Implantable Drug Delivery Systems Market Challenges
11.4 Implantable Drug Delivery Systems Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
